Symbiox Investment & Trading Co Ltd Intrinsic Value
SYMBIOX · Financial Services · Current price ₹1.58
Is Symbiox Investment & Trading Co Ltd undervalued?
DocStoX estimates the fair value of Symbiox Investment & Trading Co Ltd at ₹7 per share, versus the current market price of ₹2. That puts the stock about +331.5% below our fair-value estimate, which we read as "Expensive". Our confidence in this estimate is low.
How this fair value is calculated
This estimate blends 2 independent methods: Excess-return (book value) (₹9), Relative P/E (₹1). We weight each by its reliability and skip any method whose inputs look untrustworthy — "no DCF beats a wrong DCF". This is the same deterministic engine that powers DocStoX stock pages; there is no guesswork or AI-generated number here.
Bear, base and bull scenarios
Our scenarios span ₹1 (bear) to ₹7 (base) to ₹9 (bull). A margin of safety means buying meaningfully below the base case — the wider the gap, the more room for error in the assumptions.
Margin of safety
Value investors demand a margin of safety — a discount to intrinsic value that protects against being wrong. At ₹2 versus an intrinsic value of ₹7, Symbiox Investment & Trading Co Ltd currently offers +331.5% of margin.
More on Symbiox Investment & Trading Co Ltd
DocStoX estimates are generated by a deterministic valuation engine from reported financials — for informational purposes only, not investment advice. Consult a SEBI-registered advisor before investing.